Widely used:Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹7,911 Cr
P/E Ratio
135.67
P/B Ratio
9.11
Industry P/E
52.15
Debt to Equity
0.83
ROE
4.99 %
ROCE
12.79 %
Div. Yield
0 %
Book Value
62.31
EPS
3.97
CFO
₹1,427.40 Cr
EBITDA
₹1,632.64 Cr
Net Profit
₹-232.62 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| 15.62 | 8.14 | 9.79 | 55.93 | 24.91 | 51.06 | -- |
|
BSE Healthcare
| -4.95 | 1.92 | -0.50 | 24.13 | 20.27 | 23.08 | 9.93 |
|
BSE Small Cap
| -10.08 | 4.17 | -3.87 | 5.97 | 18.98 | 35.50 | 15.85 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| 33.90 | 27.15 | 20.25 | 45.54 | 56.12 | -46.27 | -29.11 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 | -6.85 | -23.41 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 420.60 | 3,850.72 | 25.48 | 30.16 | |
| 1,498.20 | 9,827.04 | 50.68 | 15.84 | |
| 5,598.45 | 6,125.97 | 29.68 | 22.17 | |
| 501.20 | 4,824.94 | 37.06 | 14.41 |
1 min read•By Research Desk
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery;... and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat; operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. It operates cancer centers. The company was founded in 1989 and is based in Bengaluru, India. Read more
Incorporated
1998
Chairman
B S Ajai Kumar
Managing Director
--
Group
HCG
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Healthcare Global Enterprises Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Healthcare Global Enterprises Ltd stood at ₹ 3,067 Cr as on 31-Dec-24
The share price of Healthcare Global Enterprises Ltd is ₹565.55 (NSE) and ₹567.45 (BSE) as of 24-Apr-2025 IST. Healthcare Global Enterprises Ltd has given a return of 24.91% in the last 3 years.
Healthcare Global Enterprises Ltd has a market capitalisation of ₹ 7,911 Cr as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Healthcare Global Enterprises Ltd is 9.11 times as on 24-Apr-2025, a 21% premium to its peers’ median range of 7.50 times.
The P/E ratio of Healthcare Global Enterprises Ltd is 135.67 times as on 24-Apr-2025, a 160% premium to its peers’ median range of 52.15 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Healthcare Global Enterprises Ltd and enter the required number of quantities and click on buy to purchase the shares of Healthcare Global Enterprises Ltd.
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates multi-specialty hospitals under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat; operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. It operates cancer centers. The company was founded in 1989 and is based in Bengaluru, India.
The promoters of Healthcare Global Enterprises Ltd are ACESO COMPANY PTE. LTD. and AJAIKUMAR B S. They collectively own 70.75 per cent of the total equity. The chairman of the company is B S Ajai Kumar
The promoters of Healthcare Global Enterprises Ltd have pledged 3.56% of the total equity as on Mar-25.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
9,638
|
|
|
6,106
|
|
|
4,889
|
|
|
3,869
|
| Healthcare Global Enterprises Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
6.56
|
|
Operating margin(%)
|
8.18
|
|
Net Margin(%)
|
2.99
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Healthcare Global Enterprises Ltd was ₹58 Cr.
₹-10.00
(
